CoChat

Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Abstract

Type 3 immune response defined by increased IL-22 production drives fibrosis during chronic liver injury via enhanced TGF-β signaling.

Overview

Integrity signals

Registry

Crossref · 10.1126/sciimmunol.aar7754

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 51 references

Cited by

See all 163

Metadata

Authors
Fabre, T., Molina, M. F., Soucy, G., Goulet, J.-P., Willems, B., Villeneuve, J.-P., Bilodeau, M., & Shoukry, N. H.
Affiliations
  • Centre Hospitalier de l’Université de Montréal (CA)
  • Caprion (Canada) (CA)
Corresponding author
Shoukry, Naglaa H.
Venue
Science Immunology
Published
2018-10-26
Volume
3
Issue
28
ISSN
2470-9468 (ISSN-L)
OpenAlex
W2898290288
Cited by
155
References
52
Citations by year
2026: 17 · 2025: 25 · 2024: 19 · 2023: 23 · 2022: 23 · 2021: 25 · 2020: 15 · 2019: 7 · 2018: 1
FWCI
7.59
Type
journal article
Language
en
Open access
closed
Locations
  • Science Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Canadian Institutes of Health Research (HEO-115696)
  • Fonds de Recherche du Québec - Santé
  • Canadian Liver Foundation (N/A)
  • Fonds de recherche du Québec – Santé (FRQS) AIDS and Infectious Disease Network
  • Canadian Network on Hepatitis C
  • Novartis/Canadian Liver Foundation Hepatology Research Chair (N/A)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
liver fibrosis, IL-17A, IL-22, TGF-beta signaling, hepatic stellate cells, p38 MAPK, neutrophils, mast cells, IL-22RA1, aryl hydrocarbon receptor, chronic liver injury, thioacetamide, carbon tetrachloride
MeSH terms
Interleukin-22, Animals, Azo Compounds, Disease Models, Animal, Dose-Response Relationship, Drug, Female, Interleukins, Liver Cirrhosis, Male, Mice, Inbred C57BL, Pyrazoles, Transforming Growth Factor beta, Mice, Knockout, Interleukin-17, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.